Team:Westminster/Results
From 2012.igem.org
(15 intermediate revisions not shown) | |||
Line 341: | Line 341: | ||
<div id="home-main-text"> | <div id="home-main-text"> | ||
<h1>WIKI Notebook & Results</h1> | <h1>WIKI Notebook & Results</h1> | ||
- | + | <p class=MsoNormal><span style='font-size:12.0pt;line-height:115%;font-family: | |
- | <p><b> | + | "Arial","sans-serif";color:red'>PROJECT DESIGN: WEEK 1 (16 July 16 2012)<o:p></o:p></span></p> |
- | <p><span style=' | + | |
- | <p><span style='color:red'> | + | <p class=MsoNormal><span style='font-size:12.0pt;line-height:115%;font-family: |
+ | "Arial","sans-serif"'>The first <span class=GramE>criteria for the project is</span> | ||
+ | to identify the most prevalent ALDH isoforms which have been identified in the | ||
+ | literature as being markers of cancer stem cells. ALDH1A1 was identified as the | ||
+ | most prevalent isoform and ALDH1A3 and ALDH 3A1 have also been identified. ALDH2 | ||
+ | has been selected as a control as its expression may be up-regulated by | ||
+ | introducing alcohol. <o:p></o:p></span></p> | ||
+ | |||
+ | <p class=MsoNormal><span style='font-size:12.0pt;line-height:115%;font-family: | ||
+ | "Arial","sans-serif"'>WEEK 2<o:p></o:p></span></b></p> | ||
+ | |||
+ | <p class=MsoNormal><span style='font-size:12.0pt;line-height:115%;font-family: | ||
+ | "Arial","sans-serif"'>This week a protocol for identifying the promoter | ||
+ | sequences of the ALDH isoforms has been designed. <o:p></o:p></span></p> | ||
+ | |||
+ | <p class=MsoNormal><span style='font-size:12.0pt;line-height:115%;font-family: | ||
+ | "Arial","sans-serif"'>PROTOCOL<o:p></o:p></span></p> | ||
+ | |||
+ | <p class=MsoNormal><span style='font-size:12.0pt;line-height:115%;font-family: | ||
+ | "Arial","sans-serif"'>1. Identify the start of the protein sequence (the | ||
+ | promoter will be upstream of the start site). <o:p></o:p></span></p> | ||
+ | |||
+ | <p class=MsoNormal><span style='font-size:12.0pt;line-height:115%;font-family: | ||
+ | "Arial","sans-serif"'>2. Locate the TATA box within the region up-stream of the | ||
+ | protein sequence.<o:p></o:p></span></p> | ||
+ | |||
+ | <p class=MsoNormal><span style='font-size:12.0pt;line-height:115%;font-family: | ||
+ | "Arial","sans-serif"'>3. Select 1000bp up-stream of the protein start site to | ||
+ | include the TATA box.<o:p></o:p></span></p> | ||
+ | |||
+ | <p class=MsoNormal><span style='font-size:12.0pt;line-height:115%;font-family: | ||
+ | "Arial","sans-serif"'>4. Compare selected promoter sequence with commercial | ||
+ | sequences. <o:p></o:p></span></p> | ||
+ | |||
+ | <p class=MsoNormal><span style='font-size:12.0pt;line-height:115%;font-family: | ||
+ | "Arial","sans-serif"'>5. Analyse sequences for illegal sites.<o:p></o:p></span></p> | ||
+ | |||
+ | <p class=MsoNormal><span style='font-size:12.0pt;line-height:115%;font-family: | ||
+ | "Arial","sans-serif"'>(6. Later we identified the European Promoter Database | ||
+ | and compared selected sequences to sequences there and were able to select sequences | ||
+ | which excluded illegal sites. <o:p></o:p></span></p> | ||
+ | |||
+ | <p class=MsoNormal><span style='font-size:12.0pt;line-height:115%;font-family: | ||
+ | "Arial","sans-serif"'>Primers to amplify the ALDH promoters were designed as | ||
+ | follows:<o:p></o:p></span></p> | ||
+ | |||
+ | <table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0 | ||
+ | style='border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt; | ||
+ | mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'> | ||
+ | <td width=111 valign=top style='width:83.4pt;border:solid windowtext 1.0pt; | ||
+ | mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'>pALDH1A1-FWD<o:p></o:p></span></p> | ||
+ | </td> | ||
+ | <td width=505 valign=top style='width:378.7pt;border:solid windowtext 1.0pt; | ||
+ | border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt: | ||
+ | solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:12.0pt; | ||
+ | font-family:"Arial","sans-serif";color:red'>GTTTCTTCGAATTCGCGGCCGCTTCTAGAG</span></b><span | ||
+ | style='font-size:12.0pt;font-family:"Arial","sans-serif"'>CATCATATGACTTTTTTCAAC<o:p></o:p></span></p> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'><o:p> </o:p></span></p> | ||
+ | </td> | ||
+ | </tr> | ||
+ | <tr style='mso-yfti-irow:1'> | ||
+ | <td width=111 valign=top style='width:83.4pt;border:solid windowtext 1.0pt; | ||
+ | border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; | ||
+ | padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'>pALDH1A1-RWD<o:p></o:p></span></p> | ||
+ | </td> | ||
+ | <td width=505 valign=top style='width:378.7pt;border-top:none;border-left: | ||
+ | none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; | ||
+ | mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; | ||
+ | mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:12.0pt; | ||
+ | font-family:"Arial","sans-serif";color:#4F81BD;mso-themecolor:accent1'>GTTTCTTCCTGCAGCGGCCGCTACTAGTA</span></b><span | ||
+ | style='font-size:12.0pt;font-family:"Arial","sans-serif"'>TTCTGATTCGGCTCCTGGAA<o:p></o:p></span></p> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'><o:p> </o:p></span></p> | ||
+ | </td> | ||
+ | </tr> | ||
+ | <tr style='mso-yfti-irow:2'> | ||
+ | <td width=111 valign=top style='width:83.4pt;border:solid windowtext 1.0pt; | ||
+ | border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; | ||
+ | padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'>pALDH2-FWD<o:p></o:p></span></p> | ||
+ | </td> | ||
+ | <td width=505 valign=top style='width:378.7pt;border-top:none;border-left: | ||
+ | none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; | ||
+ | mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; | ||
+ | mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:12.0pt; | ||
+ | font-family:"Arial","sans-serif";color:red'>GTTTCTTCGAATTCGCGGCCGCTTCTAGAG</span></b><span | ||
+ | style='font-size:12.0pt;font-family:"Arial","sans-serif"'>CAGAGAAGGAAGGGAGTCTTGGTTATC<o:p></o:p></span></p> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'><o:p> </o:p></span></p> | ||
+ | </td> | ||
+ | </tr> | ||
+ | <tr style='mso-yfti-irow:3'> | ||
+ | <td width=111 valign=top style='width:83.4pt;border:solid windowtext 1.0pt; | ||
+ | border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; | ||
+ | padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'>pALDH2-RWD<o:p></o:p></span></p> | ||
+ | </td> | ||
+ | <td width=505 valign=top style='width:378.7pt;border-top:none;border-left: | ||
+ | none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; | ||
+ | mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; | ||
+ | mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:12.0pt; | ||
+ | font-family:"Arial","sans-serif";color:#4F81BD;mso-themecolor:accent1'>GTTTCTTCCTGCAGCGGCCGCTACTAGTA</span></b><span | ||
+ | style='font-size:12.0pt;font-family:"Arial","sans-serif"'>CTGATGCTCCAGGTGAAGAGACC<o:p></o:p></span></p> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'><o:p> </o:p></span></p> | ||
+ | </td> | ||
+ | </tr> | ||
+ | <tr style='mso-yfti-irow:4'> | ||
+ | <td width=111 valign=top style='width:83.4pt;border:solid windowtext 1.0pt; | ||
+ | border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; | ||
+ | padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'>pALDH1A3-FWD<o:p></o:p></span></p> | ||
+ | </td> | ||
+ | <td width=505 valign=top style='width:378.7pt;border-top:none;border-left: | ||
+ | none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; | ||
+ | mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; | ||
+ | mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:12.0pt; | ||
+ | font-family:"Arial","sans-serif";color:red'>GTTTCTTCGAATTCGCGGCCGCTTCTAGAG</span></b><span | ||
+ | style='font-size:12.0pt;font-family:"Arial","sans-serif"'>ATCGAGGTATAATTTATGC<o:p></o:p></span></p> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'><o:p> </o:p></span></p> | ||
+ | </td> | ||
+ | </tr> | ||
+ | <tr style='mso-yfti-irow:5'> | ||
+ | <td width=111 valign=top style='width:83.4pt;border:solid windowtext 1.0pt; | ||
+ | border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; | ||
+ | padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'>pALDH1A3-RWD<o:p></o:p></span></p> | ||
+ | </td> | ||
+ | <td width=505 valign=top style='width:378.7pt;border-top:none;border-left: | ||
+ | none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; | ||
+ | mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; | ||
+ | mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:12.0pt; | ||
+ | font-family:"Arial","sans-serif";color:#4F81BD;mso-themecolor:accent1'>GTTTCTTCCTGCAGCGGCCGCTACTAGTA</span></b><span | ||
+ | style='font-size:12.0pt;font-family:"Arial","sans-serif"'>TCCCTGGCCCGAGGCGCCCTA<o:p></o:p></span></p> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:12.0pt; | ||
+ | font-family:"Arial","sans-serif";color:red'><o:p> </o:p></span></b></p> | ||
+ | </td> | ||
+ | </tr> | ||
+ | <tr style='mso-yfti-irow:6'> | ||
+ | <td width=111 valign=top style='width:83.4pt;border:solid windowtext 1.0pt; | ||
+ | border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; | ||
+ | padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'>pALDH3A1-Com-FWD<o:p></o:p></span></p> | ||
+ | </td> | ||
+ | <td width=505 valign=top style='width:378.7pt;border-top:none;border-left: | ||
+ | none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; | ||
+ | mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; | ||
+ | mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:12.0pt; | ||
+ | font-family:"Arial","sans-serif";color:red'>GTTTCTTCGAATTCGCGGCCGCTTCTAGAG</span></b><span | ||
+ | style='font-size:12.0pt;font-family:"Arial","sans-serif"'>TATAGGCGTGAGCCACCG<o:p></o:p></span></p> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'><o:p> </o:p></span></p> | ||
+ | </td> | ||
+ | </tr> | ||
+ | <tr style='mso-yfti-irow:7'> | ||
+ | <td width=111 valign=top style='width:83.4pt;border:solid windowtext 1.0pt; | ||
+ | border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; | ||
+ | padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'>pALDH3A1-RWD<o:p></o:p></span></p> | ||
+ | </td> | ||
+ | <td width=505 valign=top style='width:378.7pt;border-top:none;border-left: | ||
+ | none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; | ||
+ | mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; | ||
+ | mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:12.0pt; | ||
+ | font-family:"Arial","sans-serif";color:#4F81BD;mso-themecolor:accent1'>GTTTCTTCCTGCAGCGGCCGCTACTAGTA</span></b><span | ||
+ | style='font-size:12.0pt;font-family:"Arial","sans-serif"'>CGGCCTCGCTGATCTTGC<o:p></o:p></span></p> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'><o:p> </o:p></span></p> | ||
+ | </td> | ||
+ | </tr> | ||
+ | <tr style='mso-yfti-irow:8;mso-yfti-lastrow:yes'> | ||
+ | <td width=111 valign=top style='width:83.4pt;border:solid windowtext 1.0pt; | ||
+ | border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; | ||
+ | padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'>pALDH3A1-Com-RWD<o:p></o:p></span></p> | ||
+ | </td> | ||
+ | <td width=505 valign=top style='width:378.7pt;border-top:none;border-left: | ||
+ | none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; | ||
+ | mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; | ||
+ | mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:12.0pt; | ||
+ | font-family:"Arial","sans-serif";color:#4F81BD;mso-themecolor:accent1'>GTTTCTTCCTGCAGCGGCCGCTACTAGTA</span></b><span | ||
+ | style='font-size:12.0pt;font-family:"Arial","sans-serif"'>GACAGAGAGCACCTGCAGCT<o:p></o:p></span></p> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'><o:p> </o:p></span></p> | ||
+ | </td> | ||
+ | </tr> | ||
+ | </table> | ||
+ | |||
+ | <p class=MsoNormal><span style='font-size:12.0pt;line-height:115%;font-family: | ||
+ | "Arial","sans-serif"'><o:p> </o:p></span></p> | ||
+ | |||
+ | <p class=MsoNormal><span style='font-size:12.0pt;line-height:115%;font-family: | ||
+ | "Arial","sans-serif"'>WEEK3<o:p></o:p></span></p> | ||
+ | |||
+ | <p class=MsoNormal><span style='font-size:12.0pt;line-height:115%;font-family: | ||
+ | "Arial","sans-serif"'>Search for template DNA to construct experimental parts | ||
+ | has begun. Search of the Registry found no parts which could be used for our | ||
+ | design. We have contacted DTU-Denmark 2011 <span class=SpellE>iGEM</span> team | ||
+ | to obtain some of their parts directly. Parts requested from DTU are on | ||
+ | plasmids BBa_K678049 and BBa_K678056. <span class=GramE>Serrano labs has</span> | ||
+ | also been identified as a source of mammalian parts and MTA transfer is being | ||
+ | set up to allow us to receive the parts. <o:p></o:p></span></p> | ||
+ | |||
+ | <p class=MsoNormal><span style='font-size:12.0pt;line-height:115%;font-family: | ||
+ | "Arial","sans-serif"'>WEEK 4<o:p></o:p></span></p> | ||
+ | |||
+ | <p class=MsoNormal><span style='font-size:12.0pt;line-height:115%;font-family: | ||
+ | "Arial","sans-serif"'>This week was spent designing construct 3 of our project, | ||
+ | the construct for selectively killing Cancer stem cells based on their | ||
+ | expression of ALDH. Protocols for user cloning were also studied this week. <o:p></o:p></span></p> | ||
+ | |||
+ | <p class=MsoNormal><span style='font-size:12.0pt;line-height:115%;font-family: | ||
+ | "Arial","sans-serif"'>WEEK 5<o:p></o:p></span></p> | ||
+ | |||
+ | <p class=MsoNormal><span style='font-size:12.0pt;line-height:115%;font-family: | ||
+ | "Arial","sans-serif"'>Constructs using the DTU parts have been designed. <o:p></o:p></span></p> | ||
+ | |||
+ | |||
+ | |||
+ | <p class=MsoNormal><span style='font-size:12.0pt;line-height:115%;font-family: | ||
+ | "Arial","sans-serif"'>Friday was spent at the UK team meet-up.<o:p></o:p></span></p> | ||
+ | |||
+ | <p class=MsoNormal><span style='font-size:12.0pt;line-height:115%;font-family: | ||
+ | "Arial","sans-serif"'>WEEK 6<o:p></o:p></span></p> | ||
+ | |||
+ | <p class=MsoNormal><span style='font-size:12.0pt;line-height:115%;font-family: | ||
+ | "Arial","sans-serif"'>Protocols for the lab have been put together and orders | ||
+ | for reagents and consumables ordered. <span style='mso-spacerun:yes'> </span><o:p></o:p></span></p> | ||
+ | |||
+ | <p class=MsoNormal><span style='font-size:12.0pt;line-height:115%;font-family: | ||
+ | "Arial","sans-serif"'>WEEK 7<o:p></o:p></span></p> | ||
+ | |||
+ | <p class=MsoNormal><span class=GramE><span style='font-size:12.0pt;line-height: | ||
+ | 115%;font-family:"Arial","sans-serif"'>Design of linker primers using PHUSER | ||
+ | site (<a href="http://www.cbs.dtu.dk/services/PHUSER/">http://www.cbs.dtu.dk/services/PHUSER/</a>).</span></span><span | ||
+ | style='font-size:12.0pt;line-height:115%;font-family:"Arial","sans-serif"'> Mutagenic | ||
+ | primers were also designed for the DTU parts which we intend to use. <o:p></o:p></span></p> | ||
+ | |||
+ | <p class=MsoNormal><span style='font-size:12.0pt;line-height:115%;font-family: | ||
+ | "Arial","sans-serif"'>Linker primers are as follows:<o:p></o:p></span></p> | ||
+ | |||
+ | <table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0 | ||
+ | style='border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt; | ||
+ | mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'> | ||
+ | <td width=168 valign=top style='width:125.9pt;border:solid windowtext 1.0pt; | ||
+ | mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'>ALDH | ||
+ | linker- FW<o:p></o:p></span></p> | ||
+ | </td> | ||
+ | <td width=448 valign=top style='width:336.2pt;border:solid windowtext 1.0pt; | ||
+ | border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt: | ||
+ | solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span class=SpellE><span style='font-size:12.0pt;font-family:"Arial","sans-serif"; | ||
+ | color:red'>gggtttaau</span><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'>gtttcttcgaattcgcggccgc</span></span><span | ||
+ | style='font-size:12.0pt;font-family:"Arial","sans-serif"'><o:p></o:p></span></p> | ||
+ | </td> | ||
+ | </tr> | ||
+ | <tr style='mso-yfti-irow:1'> | ||
+ | <td width=168 valign=top style='width:125.9pt;border:solid windowtext 1.0pt; | ||
+ | border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; | ||
+ | padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'>ALDH | ||
+ | linker- RV<o:p></o:p></span></p> | ||
+ | </td> | ||
+ | <td width=448 valign=top style='width:336.2pt;border-top:none;border-left: | ||
+ | none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; | ||
+ | mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; | ||
+ | mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span class=SpellE><span style='font-size:12.0pt;font-family:"Arial","sans-serif"; | ||
+ | color:red'>atggtggcggu</span><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'>ttcttcctgcagcggccg</span></span><span | ||
+ | style='font-size:12.0pt;font-family:"Arial","sans-serif"'><o:p></o:p></span></p> | ||
+ | </td> | ||
+ | </tr> | ||
+ | <tr style='mso-yfti-irow:2'> | ||
+ | <td width=168 valign=top style='width:125.9pt;border:solid windowtext 1.0pt; | ||
+ | border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; | ||
+ | padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'>m-CHERRY-FW<o:p></o:p></span></p> | ||
+ | </td> | ||
+ | <td width=448 valign=top style='width:336.2pt;border-top:none;border-left: | ||
+ | none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; | ||
+ | mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; | ||
+ | mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span class=SpellE><span style='font-size:12.0pt;font-family:"Arial","sans-serif"; | ||
+ | color:red'>accgccaccau</span><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'>ggtgagcaagggcgagga</span></span><span | ||
+ | style='font-size:12.0pt;font-family:"Arial","sans-serif"'><o:p></o:p></span></p> | ||
+ | </td> | ||
+ | </tr> | ||
+ | <tr style='mso-yfti-irow:3'> | ||
+ | <td width=168 valign=top style='width:125.9pt;border:solid windowtext 1.0pt; | ||
+ | border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; | ||
+ | padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'>m-CHERRY-RV<o:p></o:p></span></p> | ||
+ | </td> | ||
+ | <td width=448 valign=top style='width:336.2pt;border-top:none;border-left: | ||
+ | none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; | ||
+ | mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; | ||
+ | mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span class=SpellE><span style='font-size:12.0pt;font-family:"Arial","sans-serif"; | ||
+ | color:red'>agttcttgu</span><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'>acagctcgtccatgccgc</span></span><span | ||
+ | style='font-size:12.0pt;font-family:"Arial","sans-serif"'><o:p></o:p></span></p> | ||
+ | </td> | ||
+ | </tr> | ||
+ | <tr style='mso-yfti-irow:4'> | ||
+ | <td width=168 valign=top style='width:125.9pt;border:solid windowtext 1.0pt; | ||
+ | border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; | ||
+ | padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'>SV-40- | ||
+ | FW<o:p></o:p></span></p> | ||
+ | </td> | ||
+ | <td width=448 valign=top style='width:336.2pt;border-top:none;border-left: | ||
+ | none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; | ||
+ | mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; | ||
+ | mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span class=SpellE><span style='font-size:12.0pt;font-family:"Arial","sans-serif"; | ||
+ | color:red'>caagaacu</span><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'>tgtttattgcagcttata</span></span><span | ||
+ | style='font-size:12.0pt;font-family:"Arial","sans-serif"'><o:p></o:p></span></p> | ||
+ | </td> | ||
+ | </tr> | ||
+ | <tr style='mso-yfti-irow:5'> | ||
+ | <td width=168 valign=top style='width:125.9pt;border:solid windowtext 1.0pt; | ||
+ | border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; | ||
+ | padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'>SV-40-RV<o:p></o:p></span></p> | ||
+ | </td> | ||
+ | <td width=448 valign=top style='width:336.2pt;border-top:none;border-left: | ||
+ | none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; | ||
+ | mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; | ||
+ | mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span class=SpellE><span style='font-size:12.0pt;font-family:"Arial","sans-serif"; | ||
+ | color:red'>agacatgau</span><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'>aagatacattgatgagttt</span></span><span | ||
+ | style='font-size:12.0pt;font-family:"Arial","sans-serif"'><o:p></o:p></span></p> | ||
+ | </td> | ||
+ | </tr> | ||
+ | <tr style='mso-yfti-irow:6'> | ||
+ | <td width=168 valign=top style='width:125.9pt;border:solid windowtext 1.0pt; | ||
+ | border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; | ||
+ | padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'>HYGROMYCIN-FW<o:p></o:p></span></p> | ||
+ | </td> | ||
+ | <td width=448 valign=top style='width:336.2pt;border-top:none;border-left: | ||
+ | none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; | ||
+ | mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; | ||
+ | mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span class=SpellE><span style='font-size:12.0pt;font-family:"Arial","sans-serif"; | ||
+ | color:red'>atcatgtcu</span><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'>gccagcaggcagaagtatgcaaagc</span></span><span | ||
+ | style='font-size:12.0pt;font-family:"Arial","sans-serif"'><o:p></o:p></span></p> | ||
+ | </td> | ||
+ | </tr> | ||
+ | <tr style='mso-yfti-irow:7'> | ||
+ | <td width=168 valign=top style='width:125.9pt;border:solid windowtext 1.0pt; | ||
+ | border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; | ||
+ | padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'>HYGROMYCIN-RV<o:p></o:p></span></p> | ||
+ | </td> | ||
+ | <td width=448 valign=top style='width:336.2pt;border-top:none;border-left: | ||
+ | none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; | ||
+ | mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; | ||
+ | mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span class=SpellE><span style='font-size:12.0pt;font-family:"Arial","sans-serif"; | ||
+ | color:red'>agtagttu</span><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'>cttcctgcagcggccgct</span></span><span | ||
+ | style='font-size:12.0pt;font-family:"Arial","sans-serif"'><o:p></o:p></span></p> | ||
+ | </td> | ||
+ | </tr> | ||
+ | <tr style='mso-yfti-irow:8'> | ||
+ | <td width=168 valign=top style='width:125.9pt;border:solid windowtext 1.0pt; | ||
+ | border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; | ||
+ | padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'>pSB1C3-FW<o:p></o:p></span></p> | ||
+ | </td> | ||
+ | <td width=448 valign=top style='width:336.2pt;border-top:none;border-left: | ||
+ | none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; | ||
+ | mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; | ||
+ | mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span class=SpellE><span style='font-size:12.0pt;font-family:"Arial","sans-serif"; | ||
+ | color:red'>aaactacu</span><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'>agtagcggccgctgcagt</span></span><span | ||
+ | style='font-size:12.0pt;font-family:"Arial","sans-serif"'><o:p></o:p></span></p> | ||
+ | </td> | ||
+ | </tr> | ||
+ | <tr style='mso-yfti-irow:9'> | ||
+ | <td width=168 valign=top style='width:125.9pt;border:solid windowtext 1.0pt; | ||
+ | border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; | ||
+ | padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'>pSB1C3-RV<o:p></o:p></span></p> | ||
+ | </td> | ||
+ | <td width=448 valign=top style='width:336.2pt;border-top:none;border-left: | ||
+ | none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; | ||
+ | mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; | ||
+ | mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span class=SpellE><span style='font-size:12.0pt;font-family:"Arial","sans-serif"; | ||
+ | color:red'>ggtcttaau</span><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'>ctctagaagcggccgcga</span></span><span | ||
+ | style='font-size:12.0pt;font-family:"Arial","sans-serif"'><o:p></o:p></span></p> | ||
+ | </td> | ||
+ | </tr> | ||
+ | <tr style='mso-yfti-irow:10'> | ||
+ | <td width=168 valign=top style='width:125.9pt;border:solid windowtext 1.0pt; | ||
+ | border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; | ||
+ | padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'>Neomycin-FW<o:p></o:p></span></p> | ||
+ | </td> | ||
+ | <td width=448 valign=top style='width:336.2pt;border-top:none;border-left: | ||
+ | none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; | ||
+ | mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; | ||
+ | mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span class=SpellE><span style='font-size:12.0pt;font-family:"Arial","sans-serif"; | ||
+ | color:red'>aaacctgu</span><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'>ggaatgtgtgtcagttag</span></span><span | ||
+ | style='font-size:12.0pt;font-family:"Arial","sans-serif"'><o:p></o:p></span></p> | ||
+ | </td> | ||
+ | </tr> | ||
+ | <tr style='mso-yfti-irow:11;mso-yfti-lastrow:yes'> | ||
+ | <td width=168 valign=top style='width:125.9pt;border:solid windowtext 1.0pt; | ||
+ | border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; | ||
+ | padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'>Neomycin-RV<o:p></o:p></span></p> | ||
+ | </td> | ||
+ | <td width=448 valign=top style='width:336.2pt;border-top:none;border-left: | ||
+ | none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; | ||
+ | mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; | ||
+ | mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> | ||
+ | <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height: | ||
+ | normal'><span class=SpellE><span style='font-size:12.0pt;font-family:"Arial","sans-serif"; | ||
+ | color:red'>agaacatgau</span><span style='font-size:12.0pt;font-family:"Arial","sans-serif"'>aagatacattgatgagtttgg</span></span><span | ||
+ | style='font-size:12.0pt;font-family:"Arial","sans-serif"'><o:p></o:p></span></p> | ||
+ | </td> | ||
+ | </tr> | ||
+ | </table> | ||
+ | |||
+ | <p class=MsoNormal><span style='font-size:12.0pt;line-height:115%;font-family: | ||
+ | "Arial","sans-serif"'><span style='mso-spacerun:yes'> </span><o:p></o:p></span></p> | ||
+ | |||
+ | <p class=MsoNormal><span style='font-size:12.0pt;line-height:115%;font-family: | ||
+ | "Arial","sans-serif"'><o:p> </o:p></span></p> | ||
+ | |||
+ | <p><b>WETLAB WEEK 1 (12 September 2012)</b></p> | ||
+ | <P> After months of planning we are finally in the lab!<P> | ||
+ | <p><span style='color:red'>Wednesday</span></p> | ||
<p><span style='color:red'>AIM:</span> The primers for | <p><span style='color:red'>AIM:</span> The primers for | ||
amplification of the ALDH promoter sequences have arrived. These primers have | amplification of the ALDH promoter sequences have arrived. These primers have | ||
Line 373: | Line 865: | ||
<p>Sample 2: 50.4ng/<span style='font-family:"Times New Roman"'> µ</span>L with purity ration 260/280 = 1.30</p> | <p>Sample 2: 50.4ng/<span style='font-family:"Times New Roman"'> µ</span>L with purity ration 260/280 = 1.30</p> | ||
<p>Sample 3: 46.4ng/<span style='font-family:"Times New Roman"'> µ</span>L with purity ration 260/280 = 1.28</p> | <p>Sample 3: 46.4ng/<span style='font-family:"Times New Roman"'> µ</span>L with purity ration 260/280 = 1.28</p> | ||
- | <p><span style=' | + | <p><span style='color:red'>Thursday</span></p> |
<p><span style='color:red'>AIM:</span> Amplification of ALDH | <p><span style='color:red'>AIM:</span> Amplification of ALDH | ||
promoters. A PCR reaction was carried out as before with the same reaction mix | promoters. A PCR reaction was carried out as before with the same reaction mix | ||
Line 400: | Line 892: | ||
illegal site. </span></p> | illegal site. </span></p> | ||
<p><span style='color:black; | <p><span style='color:black; | ||
- | + | <p><span style='color:red'>Friday</span></p> | |
<p><span style='color:red'> </span>We have decided to try a touchdown | <p><span style='color:red'> </span>We have decided to try a touchdown | ||
PCR reaction in order to try to amplify the other parts, particularly ALDH1A1. | PCR reaction in order to try to amplify the other parts, particularly ALDH1A1. | ||
Line 573: | Line 1,065: | ||
class=SpellE>Taq</span> PCR was set up according to manufacturer protocol. PCR | class=SpellE>Taq</span> PCR was set up according to manufacturer protocol. PCR | ||
was run overnight. </p> | was run overnight. </p> | ||
- | <p><span style='color:red'> | + | <p><span style='color:red'>Tuesday</span></p> |
<p><span style='color:black;'>The overnight | <p><span style='color:black;'>The overnight | ||
PCR was analysed. </span></p> | PCR was analysed. </span></p> | ||
Line 583: | Line 1,075: | ||
<p>ALDH 1A3 – <span style='color:red'>Bba_K940002</span></p> | <p>ALDH 1A3 – <span style='color:red'>Bba_K940002</span></p> | ||
<p>ALDH3A1 – <span style='color:red'>BBa_K940003</span></p> | <p>ALDH3A1 – <span style='color:red'>BBa_K940003</span></p> | ||
- | <p><span style='color:red'> | + | <p><span style='color:red'>Wednesday</span></p> |
<p>CONCLUSION:</p> | <p>CONCLUSION:</p> | ||
<p>Unfortunately we have not been able to achieve all that we set out | <p>Unfortunately we have not been able to achieve all that we set out | ||
- | to do in the lab. In the two and a half weeks which we had in the lab we were | + | to do in the lab. In the two and a half weeks which we have had in the lab we were |
- | able to amplify the promoter regions which we had designed and sent them to | + | able to amplify the promoter regions which we had designed and we have sent them to |
- | iGEM registry. | + | iGEM registry. These parts are currently being sequenced. </p> |
- | + | <P> Parts produced by the group<P> | |
- | + | <P> ALDH1A1 promoter BBa_K940000<P> | |
+ | <P> ALDH2 promoter BBa_K940001<P> | ||
+ | <P> ALDH1A3 promoter BBa_K940002<p> | ||
+ | <p> ALDG3A1 promoter BBa_K940003<p> | ||
+ | |||
+ | |||
+ | <p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span | ||
+ | style='font-size:12.0pt;line-height:115%;font-family:"Arial","sans-serif"'>Post | ||
+ | European Regional in Amsterdam<o:p></o:p></span></b></p> | ||
+ | |||
+ | <p class=MsoNormal><span style='font-size:12.0pt;line-height:115%;font-family: | ||
+ | "Arial","sans-serif"'>In order to test the project idea, a new approach has | ||
+ | been taken. Parts from Serrano will be used to construct the project plasmids | ||
+ | for experiment 1 and 2. Parts will be assembled using restriction-ligation. <o:p></o:p></span></p> | ||
+ | |||
+ | |||
</div><!-- #home-main-text --> | </div><!-- #home-main-text --> |
Latest revision as of 01:42, 27 October 2012
WIKI Notebook & Results
PROJECT DESIGN: WEEK 1 (16 July 16 2012)
The first criteria for the project is
to identify the most prevalent ALDH isoforms which have been identified in the
literature as being markers of cancer stem cells. ALDH1A1 was identified as the
most prevalent isoform and ALDH1A3 and ALDH 3A1 have also been identified. ALDH2
has been selected as a control as its expression may be up-regulated by
introducing alcohol.
WEEK 2
This week a protocol for identifying the promoter
sequences of the ALDH isoforms has been designed.
PROTOCOL
1. Identify the start of the protein sequence (the
promoter will be upstream of the start site).
2. Locate the TATA box within the region up-stream of the
protein sequence.
3. Select 1000bp up-stream of the protein start site to
include the TATA box.
4. Compare selected promoter sequence with commercial
sequences.
5. Analyse sequences for illegal sites.
(6. Later we identified the European Promoter Database
and compared selected sequences to sequences there and were able to select sequences
which excluded illegal sites.
Primers to amplify the ALDH promoters were designed as
follows:
pALDH1A1-FWD |
GTTTCTTCGAATTCGCGGCCGCTTCTAGAGCATCATATGACTTTTTTCAAC |
pALDH1A1-RWD |
GTTTCTTCCTGCAGCGGCCGCTACTAGTATTCTGATTCGGCTCCTGGAA |
pALDH2-FWD |
GTTTCTTCGAATTCGCGGCCGCTTCTAGAGCAGAGAAGGAAGGGAGTCTTGGTTATC |
pALDH2-RWD |
GTTTCTTCCTGCAGCGGCCGCTACTAGTACTGATGCTCCAGGTGAAGAGACC |
pALDH1A3-FWD |
GTTTCTTCGAATTCGCGGCCGCTTCTAGAGATCGAGGTATAATTTATGC |
pALDH1A3-RWD |
GTTTCTTCCTGCAGCGGCCGCTACTAGTATCCCTGGCCCGAGGCGCCCTA |
pALDH3A1-Com-FWD |
GTTTCTTCGAATTCGCGGCCGCTTCTAGAGTATAGGCGTGAGCCACCG |
pALDH3A1-RWD |
GTTTCTTCCTGCAGCGGCCGCTACTAGTACGGCCTCGCTGATCTTGC |
pALDH3A1-Com-RWD |
GTTTCTTCCTGCAGCGGCCGCTACTAGTAGACAGAGAGCACCTGCAGCT |
WEEK3
Search for template DNA to construct experimental parts
has begun. Search of the Registry found no parts which could be used for our
design. We have contacted DTU-Denmark 2011 iGEM team
to obtain some of their parts directly. Parts requested from DTU are on
plasmids BBa_K678049 and BBa_K678056. Serrano labs has
also been identified as a source of mammalian parts and MTA transfer is being
set up to allow us to receive the parts.
WEEK 4
This week was spent designing construct 3 of our project,
the construct for selectively killing Cancer stem cells based on their
expression of ALDH. Protocols for user cloning were also studied this week.
WEEK 5
Constructs using the DTU parts have been designed.
Friday was spent at the UK team meet-up.
WEEK 6
Protocols for the lab have been put together and orders
for reagents and consumables ordered.
WEEK 7
Design of linker primers using PHUSER
site (http://www.cbs.dtu.dk/services/PHUSER/). Mutagenic
primers were also designed for the DTU parts which we intend to use.
Linker primers are as follows:
ALDH
linker- FW |
gggtttaaugtttcttcgaattcgcggccgc |
ALDH
linker- RV |
atggtggcgguttcttcctgcagcggccg |
m-CHERRY-FW |
accgccaccauggtgagcaagggcgagga |
m-CHERRY-RV |
agttcttguacagctcgtccatgccgc |
SV-40-
FW |
caagaacutgtttattgcagcttata |
SV-40-RV |
agacatgauaagatacattgatgagttt |
HYGROMYCIN-FW |
atcatgtcugccagcaggcagaagtatgcaaagc |
HYGROMYCIN-RV |
agtagttucttcctgcagcggccgct |
pSB1C3-FW |
aaactacuagtagcggccgctgcagt |
pSB1C3-RV |
ggtcttaauctctagaagcggccgcga |
Neomycin-FW |
aaacctguggaatgtgtgtcagttag |
Neomycin-RV |
agaacatgauaagatacattgatgagtttgg |
WETLAB WEEK 1 (12 September 2012)
After months of planning we are finally in the lab!
Wednesday
AIM: The primers for amplification of the ALDH promoter sequences have arrived. These primers have the Biobrick overhangs. Primers were diluted to 100mM and working concentrations of primers was made up at 10mM. The first set of primers to amplify the four ALDH isoforms was set up.
PCR was set up using Pfu polymerase. Template used was whole cells (mammalian). Cells were thawed, spun down and the supernatant removed and re-suspended in 50uL DMSO. We attempted to amplify the following promoter sequences: ALDH1A1, ALDH2, ALDH1A3, ALDH3A1 (1) and ALDH3A1(2).
The cycle conditions were as follows:
Initial denaturation at 980C for 30 seconds then 30 cycles with 980C for 10 seconds, 540C for 30 seconds (annealing) and 720C for 30 seconds. Final extension was at 720C for 10 minutes and then PCR was held at 40C.
RESULTS: No bands were seen on the gel.
ANALYSIS: It is possible that the DNA template (addition of whole cells) did not become available in the reaction. Other cellular components during lysis of the cells may also have had an impact on the efficiency of the PCR reaction. We have located a protocol for crude extraction of mammalian DNA and will repeat the PCR using extracted DNA.
The extraction protocol was performed. (see protocols) Sample 1 was used as DNA template in the next PCR reaction.
Nanodrop readings were as follows:
Sample 1: 42.1ng/µL with purity ration 260/280 = 1.47
Sample 2: 50.4ng/ µL with purity ration 260/280 = 1.30
Sample 3: 46.4ng/ µL with purity ration 260/280 = 1.28
Thursday
AIM: Amplification of ALDH promoters. A PCR reaction was carried out as before with the same reaction mix and PCR conditions as Wednesday. amplify ALDH1A1 and ALDH2.
RESULTS: Amplification of ALDH1A1 was successful using the ALDH1A1-Fw and ALDH-Rv primers. The band size was as expected. ALDH 2 was also amplified using ALDH2-Fw and ALDH2-Rv primers.
ANALYSIS: We are pleased with developments thus far. Difficulties in amplification of ALDH3A1 using our the ALDH3A1(1) and ALDH3A1(2) primers was anticipated. Initial analysis in selecting an ALDH3A1 promoter region revealed a number of different options. Additionally, it was difficult to find commercial sequences which matched the gene sequence identified in NCBI. Subsequent to ordering the primers, the Eukaryotic Promoter Database was discovered. Primers for the EPD experimentally designed ALDH3A1 promoter have been ordered and will be tested when they arrive. ALDH1A1 was initially designed to be quite large and also includes an illegal site. An experimentally tested ALDH1A1 promoter has been identified on EPD. There is significant overlap between this EPD promoter sequence and the one we had designed. A new forward EPD designed primer was ordered which would give a smaller promoter and also eliminate the illegal site.
Friday
We have decided to try a touchdown PCR reaction in order to try to amplify the other parts, particularly ALDH1A1. Touchdown PCR is a faster but a more crude method of amplification in comparison to gradient PCR. After setting up the first PCR, we realised we had made a mistake (Touchdown 1). A second touchdown (Touchdown 2) was set up and run soon after with the corrections. We managed to get bands for all four promotes. These were cut from the gel, gel extracted, cut with EP (and ES for ALDH2), ligated and transformed into competent E coli.
Touchdown 1 cycle conditions were as follows:
Initial denaturation at 980C for 30 seconds then 10 cycles with 980C for 10 seconds, 620C for 30 seconds (annealing) and 720C for 1 minute 10 seconds, and annealing temperature decreasing by 10C for each cycle. Second amplification cycle was 20 cycles of 980C for 30 seconds, 520C for 10 seconds (annealing) and 720C for 1 minute 10 seconds. Final extension was at 720C for 10 minutes and then PCR was held at 40C. NOTE: In the second cycle (20 cycles) denaturation time at 980C should have been 10 seconds and annealing time should have been 30 seconds. This correction was included in Touchdown 2. Additionally, DNA template concentration was increased in Touchdown 2, by increasing the volume from 1µL per reaction to 5 µL per reaction
RESULTS: Spurious bands were obtained in the touchdown 1, but ALDH1A1 and ALDH2 were amplified. Touchdown 2 gave good results for ALDH2. For ALDH 1A3 and number of bands were seen. A faint band was observed at the expected size and this is the band which was cut from the gel. ALDH1A1 from gel 1, ALDH2 from gel 2 and ALDH3A1 from gel 2 were also cut from the gel and gel purified. Extracted DNA was run on a gel to verify the gel extraction process. Gel extracted DNA was digested with EP and ALDH2 was restricted with ES. The backbone was restricted with EP and ES aswell. Restriction digests were saved till the next day.
GEL 1-Touchdown 1
Gel 2-Touchdown 2
WEEK 2
Monday
The linker primers and the EPD primers have arrived today. Touchdown PCR to amplify the promoter parts was set up. The touchdown PCR was as before. The forward ALDH1A1(EPD) primer was paired with the reverse primer ALDH1A1-RV. The EPD designed primers for ALDH3A1 were tested.
RESULTS: It worked a dream! We have got lovely bands for ALDH1A1(EPD), ALDH2 and ALDH3A1 (EPD). However the band observed for ALDH1A3 was almost twice the expected size. The size expected was around 900bp and the size seen on the gel is around 1500bp. Parts cut from the gel were ALDH1A1 (EPD), ALDH3A1 (EPD) and ALDH2 (Wmin). DNA was gel extracted and purified. DNA was then run on a gel to verify the extraction process. An overnight digestion was set up to create the Biobrick overhang parts. Only the ALDH1A3 digest from previously was kept. The other digests were discarded at this point.
Tuesday
Today the restricted parts were cloned to the pSB1C3 backbone and transformed to E. coli. Parts cloned were the ALDH1A1 (EPD), ALDH2, ALDH1A3 and ALDH3A1. Transformed E. coli was plated to chloramphenicol plates which were incubated overnight at 370C. More plated and broth were made up ready for use. The parts required from DTU Denmark and Serrano are being arranged for delivery to us.
The following promoter parts have been mad ready.
ALDH1A1 – BBa_K940000
ALDH2 – BBa_K940001
ALDH 1A3 – Bba_K940002
ALDH3A1 – BBa_K940003
Wednesday
The linker primers were hydrated ready for use. We are still waiting for the parts from DTU and Serrano. There have been a number of issues with delivery but we are hoping to have them sorted and the parts delivered by Friday. Colony PCR was done to confirm the inserts ligated yesterday.
RESULTS: Only some of the colony PCR have worked. This may be due to suboptimal primer annealing temperatures. Colony PCR was carried out as 10µL volumes an annealing temperature was 580C using the Pfu polymerase. All colonies were inoculated to LB broth and grown overnight at 370C in a shaking incubator.
Thursday
Two samples of each of the LB cultures were selected and plasmid extracted using the QIAprep kit. PCR was then done on the extracted plasmid in order to confirm DNA insert. This was done as we had not managed to get good bands for all the colony PCR’s. The PCR results were variable. Again, this may have been due to annealing temperatures used in PCR. The samples were analysed on the nanodrop. Nanodrop results were as follows:
But it has now been found that the concentrations we have are too low to send for sequencing and still have enough for sending to iGEM parts registry. An attempt to concentrate the samples was made by putting the samples in a spin vacuum. Disaster!!! I have mixed up the lids! Colonies were quickly re-picked and inoculated to LB for growth overnight.
Friday
The parts have arrived from DTU Denmark. PCR has been set up using Pfu Turbo. DNA template used was as follows:
ALDH1A1 (BBa_K940000) extracted plasmid
mCherry (BBa_K678067) DTU
terminator (BBa_K678067) DTU
hygromycin (BBa_K678049) DTU
ALDH2 (BBa_K940000) extracted plasmid
Neomycin (BBa_K678067) DTU
Biobrick backbone (pSB1C3) unrestricted
RESULTS: Unfortunately we did not get any bands. Plasmid was visible on the gels which were run. This may indicate that the plasmid concentration was too high for the PCR reaction. Plasmid extraction was done using QIAplasmid prep kit. PCR was done on the extracted plasmid, but again the PCR was not very successful.
NEXT STEPS: Plasmid template was diluted 1/1000 and another PCR set up using the Pfu. Hygromycin is the only part which was amplified. Mg2+ was included in the reaction mix this time. DTU had reported success when they used Mg2+ . We were able to amplify hygromycin.
WEEK 3
Monday
The plasmid previously extracted was analysed on the nanodrop. The samples were made ready for sequencing and for sending to iGEM.
Nanodrop results were as follows:
ALDH1A1(1): 64.5ng/µL with purity ration 260/280 = 2.13
ALDH1A1(2): 348.5ng/µL with purity ration 260/280 =2.20
ALDH2(1): 59ng/µL with purity ration 260/280 = 1.08
ALDH2(2): 66.8ng/µL with purity ration 260/280 = 1.80
ALDH1A3(2): 166.9ng/µL with purity ration 260/280 = 2.17
ADH1A3(2): 44.5ng/µL with purity ration 260/280 = 2.20
ADH1A3(2): 174.2ng/µL with purity ration 260/280 = 2.20
ADH1A3(2): 201.4ng/µL with purity ration 260/280 = 2.22
PCR using Taq polymerase was set up. We may be able to amplify the parts using this different polymerase. Unfortunately such products could not be used for user cloning. Taq PCR was set up according to manufacturer protocol. PCR was run overnight.
Tuesday
The overnight PCR was analysed.
Promoter parts were sent for sequencing. The parts were also packaged and sent to iGEM registry.
ALDH1A1 – BBa_K940000
ALDH2 – BBa_K940001
ALDH 1A3 – Bba_K940002
ALDH3A1 – BBa_K940003
Wednesday
CONCLUSION:
Unfortunately we have not been able to achieve all that we set out to do in the lab. In the two and a half weeks which we have had in the lab we were able to amplify the promoter regions which we had designed and we have sent them to iGEM registry. These parts are currently being sequenced.
Parts produced by the group
ALDH1A1 promoter BBa_K940000
ALDH2 promoter BBa_K940001
ALDH1A3 promoter BBa_K940002
ALDG3A1 promoter BBa_K940003
Post
European Regional in Amsterdam
In order to test the project idea, a new approach has
been taken. Parts from Serrano will be used to construct the project plasmids
for experiment 1 and 2. Parts will be assembled using restriction-ligation.